Text this: Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

  _  _    _    _     _____      ___      _____   
 | \| || | || | ||  /  ___||   / _ \\   / ____|| 
 |  ' || | || | || | // __    / //\ \\ / //---`' 
 | .  || | \\_/ || | \\_\ || |  ___  ||\ \\___   
 |_|\_||  \____//   \____//  |_||  |_|| \_____|| 
 `-` -`    `---`     `---`   `-`   `-`   `----`